Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)





*Denotes required.


Unlock Efficiency and Simplify Scale-Up with AdvanceBio Oligonucleotide Columns: From Analytical to Preparative Purification

This event is now available on demand.

Event Overview: 

Various types of nucleic acids, such as antisense oligonucleotides, small interfering RNAs (siRNAs), and aptamers, are being explored for their potential in therapeutic applications. The production of synthetic oligonucleotides typically results in numerous impurities due to the inherent inefficiencies in each step of the chemical synthesis process. These impurities include deletion sequences (missing one or more nucleotides) and by-products that often form during the final deprotection or cleavage stages. 

Ion pair reversed-phase (IP-RP) chromatography is the dominant technique for the analysis and purification of oligonucleotides.  

Attend this webinar to learn how to achieve superior resolution and separation of oligo therapeutics from the many structurally similar impurities found in a crude sample. Understand how to scale up your optimized analytical method to semi-prep and preparative purification with the same column chemistry.  

Key Learning Objectives:
  • Method development strategies to optimize your oligo separation
  • Tips and tricks of how to best scale-up from analytical to semi-prep and preparative purification
  • AdvanceBio Oligonucleotide column performance evaluation and competitive comparison
Who Should Attend:
  • Analytical Method Development Scientists
  • Purification Method Development Scientists
  • Process Development Scientists
  • QC Scientists
  • CDMO Labs
Featured Speaker:

Andrea Angelo P. Tripodi
Andrea Angelo P. Tripodi
Application Chemist for BioHPLC columns and consumables
Agilent Technologies UK


Andrea Angelo Tripodi joined Agilent Technologies as an Applications Chemist in September 2019 after completing his Marie Curie PhD in Organic Chemistry, specifically focused on the development of peptide drug-conjugates for cancer therapy at ELTE University in Budapest (Hungary) within the MAGICBULLET ITN Network. He now develops LC-UV and LC/MS applications for biomolecule analysis and purification using a wide variety of approaches, including reversed-phase, size exclusion, ion exchange, hydrophilic and hydrophobic interaction chromatography.

Speaker's Email: andrea.tripodi@agilent.com
Speaker's LinkedIn: https://www.linkedin.com/in/andrea-tripodi/

For any technical questions please contact David Ambrose: dambrose@mjhlifesciences.com